- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 49/16 - Antibodies; Immunoglobulins; Fragments thereof
Patent holdings for IPC class A61K 49/16
Total number of patents in this class: 323
10-year publication summary
16
|
29
|
31
|
33
|
30
|
34
|
27
|
16
|
15
|
4
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Astellas Pharma Inc. | 1145 |
11 |
OBI Pharma, Inc. | 108 |
9 |
F. Hoffmann-La Roche AG | 7958 |
8 |
Centre National de La Recherche Scientifique | 9632 |
7 |
Commissariat à l'énergie atomique et aux energies alternatives | 10525 |
7 |
Institut Pasteur | 798 |
7 |
On Target Laboratories, LLC | 37 |
6 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
6 |
Annexon, Inc. | 53 |
5 |
Georgia State University Research Foundation, Inc. | 332 |
5 |
Prothena Biosciences Limited | 184 |
5 |
University of Southern California | 2016 |
4 |
Purdue Research Foundation | 3277 |
4 |
Beth Israel Deaconess Medical Center, Inc. | 844 |
4 |
Biogen International Neuroscience GmbH | 32 |
4 |
Genentech, Inc. | 3742 |
3 |
Janssen Pharmaceutica N.V. | 3839 |
3 |
Amgen Inc. | 3779 |
3 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
3 |
Board of Regents, The University of Texas System | 5370 |
3 |
Other owners | 216 |